Verapamil suppressed lymphocyte adhesion to vascular endothelial cells via selective inhibition of VCAM-1 expression.
Yamaguchi
M
M
Department of Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
Kuzume
M
M
Nakano
H
H
Kumada
K
K
D002448:Cell Adhesion / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D013601:T-Lymphocytes; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D019010:Vascular Cell Adhesion Molecule-1 / Q000235:genetics*; D014700:Verapamil / Q000494:pharmacology*
D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1; D014700:Verapamil